Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davis, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davis, S. M.
Related Collections
Right arrowRelated Article
NEUROLOGY 2006;66:1175-1181
© 2006 American Academy of Neurology

Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage

S. M. Davis, MD, J. Broderick, MD, M. Hennerici, MD, N. C. Brun, MD, M. N. Diringer, MD, S. A. Mayer, MD, K. Begtrup, MSc, T. Steiner, MD for the Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators

From the Department of Neurology (S.M.D.), Royal Melbourne Hospital/University of Melbourne, Parkville, Australia; University of Cincinnati Medical Center (J.B.), OH; Department of Neurology (M.H.), University of Heidelberg, Universitätsklinikum Mannheim, Germany; Novo Nordisk (N.C.B., K.B.), Bagsvaerd, Denmark; Washington University School of Medicine (M.N.D.), St. Louis, MO; Departments of Neurology and Neurosurgery (S.A.M.), Columbia University College of Physicians and Surgeons, New York, NY; and University of Heidelberg (T.S.), Germany.

Address correspondence and reprint requests to Dr. S. Davis, Department of Neurology, Royal Melbourne Hospital, Grattan Street, Parkville, Victoria 3050, Australia; e-mail: Stephen.Davis{at}mh.org.au

Background: Although volume of intracerebral hemorrhage (ICH) is a predictor of mortality, it is unknown whether subsequent hematoma growth further increases the risk of death or poor functional outcome.

Methods: To determine if hematoma growth independently predicts poor outcome, the authors performed an individual meta-analysis of patients with spontaneous ICH who had CT within 3 hours of onset and 24-hour follow-up. Placebo patients were pooled from three trials investigating dosing, safety, and efficacy of rFVIIa (n = 115), and 103 patients from the Cincinnati study (total 218). Other baseline factors included age, gender, blood glucose, blood pressure, Glasgow Coma Score (GCS), intraventricular hemorrhage (IVH), and location.

Results: Overall, 72.9% of patients exhibited some degree of hematoma growth. Percentage hematoma growth (hazard ratio [HR] 1.05 per 10% increase [95% CI: 1.03, 1.08; p < 0.0001]), initial ICH volume (HR 1.01 per mL [95% CI: 1.00, 1.02; p = 0.003]), GCS (HR 0.88 [95% CI: 0.81, 0.96; p = 0.003]), and IVH (HR 2.23 [95% CI: 1.25, 3.98; p = 0.007]) were all associated with increased mortality. Percentage growth (cumulative OR 0.84 [95% CI: 0.75, 0.92; p < 0.0001]), initial ICH volume (cumulative OR 0.94 [95% CI: 0.91, 0.97; p < 0.0001]), GCS (cumulative OR 1.46 [95% CI: 1.21, 1.82; p < 0.0001]), and age (cumulative OR 0.95 [95% CI: 0.92, 0.98; p = 0.0009]) predicted outcome modified Rankin Scale. Gender, location, blood glucose, and blood pressure did not predict outcomes.

Conclusions: Hematoma growth is an independent determinant of both mortality and functional outcome after intracerebral hemorrhage. Attenuation of growth is an important therapeutic strategy.

Disclosure: Stephen Davis, Joseph Broderick, Michael Diringer, Stephan Mayer, and Thorsten Steiner receive research support, consulting fees, and speaking honoraria from Novo Nordisk. Nikolai Brun is an employee of Novo Nordisk and has equity in excess of $10,000. Kamilla Begtrup is an employee of Novo Nordisk and has equity less than $10,000.

Received October 4, 2005. Accepted in final form January 10, 2006.


Related Article

April 25 Highlights
Neurology 2006 66: 1136-1137. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 StrokeHome page
T. Steiner and J. Bosel
Options to Restrict Hematoma Expansion After Spontaneous Intracerebral Hemorrhage
Stroke, February 1, 2010; 41(2): 402 - 409.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
C. S. Anderson, Y. Huang, H. Arima, E. Heeley, C. Skulina, M. W. Parsons, B. Peng, Q. Li, S. Su, Q. L. Tao, et al.
Effects of Early Intensive Blood Pressure-Lowering Treatment on the Growth of Hematoma and Perihematomal Edema in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT)
Stroke, February 1, 2010; 41(2): 307 - 312.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
J. E. Delgado Almandoz, A. J. Yoo, M. J. Stone, P. W. Schaefer, A. Oleinik, H. B. Brouwers, J. N. Goldstein, J. Rosand, M. H. Lev, R. G. Gonzalez, et al.
The Spot Sign Score in Primary Intracerebral Hemorrhage Identifies Patients at Highest Risk of In-Hospital Mortality and Poor Outcome Among Survivors
Stroke, January 1, 2010; 41(1): 54 - 60.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. Lou, A. Al-Hazzani, R. P. Goddeau Jr, V. Novak, and M. Selim
Relationship Between White-Matter Hyperintensities and Hematoma Volume and Growth in Patients With Intracerebral Hemorrhage
Stroke, January 1, 2010; 41(1): 34 - 40.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
K. Karki, R. A. Knight, Y. Han, D. Yang, J. Zhang, K. A. Ledbetter, M. Chopp, and D. M. Seyfried
Simvastatin and Atorvastatin Improve Neurological Outcome After Experimental Intracerebral Hemorrhage
Stroke, October 1, 2009; 40(10): 3384 - 3389.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
J. E. Delgado Almandoz, A. J. Yoo, M. J. Stone, P. W. Schaefer, J. N. Goldstein, J. Rosand, A. Oleinik, M. H. Lev, R. G. Gonzalez, and J. M. Romero
Systematic Characterization of the Computed Tomography Angiography Spot Sign in Primary Intracerebral Hemorrhage Identifies Patients at Highest Risk for Hematoma Expansion: The Spot Sign Score
Stroke, September 1, 2009; 40(9): 2994 - 3000.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
D. Rhoney and W. F. Peacock
Intravenous therapy for hypertensive emergencies, part 2
Am. J. Health Syst. Pharm., August 15, 2009; 66(16): 1448 - 1457.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
V. Aiyagari and P. B. Gorelick
Management of Blood Pressure for Acute and Recurrent Stroke
Stroke, June 1, 2009; 40(6): 2251 - 2256.
[Full Text] [PDF]

Home page
 StrokeHome page
M. L. Flaherty, O. Adeoye, P. Sekar, M. Haverbusch, C. J. Moomaw, H. Tao, J. P. Broderick, and D. Woo
The Challenge of Designing a Treatment Trial for Warfarin-Associated Intracerebral Hemorrhage
Stroke, May 1, 2009; 40(5): 1738 - 1742.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
L. H. Sansing, S. R. Messe, B. L. Cucchiara, S. N. Cohen, P. D. Lyden, S. E. Kasner, and For the CHANT Investigators
Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH
Neurology, April 21, 2009; 72(16): 1397 - 1402.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. P. Broderick
Evidence against rapid reversal of antiplatelet medications in acute intracerebral hemorrhage
Neurology, April 21, 2009; 72(16): 1376 - 1377.
[Full Text] [PDF]

Home page
 StrokeHome page
C. D. Barras, B. M. Tress, S. Christensen, L. MacGregor, M. Collins, P. M. Desmond, B. E. Skolnick, S. A. Mayer, J. P. Broderick, M. N. Diringer, et al.
Density and Shape as CT Predictors of Intracerebral Hemorrhage Growth
Stroke, April 1, 2009; 40(4): 1325 - 1331.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S. A. Mayer, S. M. Davis, B. E. Skolnick, N. C. Brun, K. Begtrup, J. P. Broderick, M. N. Diringer, and T. Steiner
Can a Subset of Intracerebral Hemorrhage Patients Benefit From Hemostatic Therapy With Recombinant Activated Factor VII?
Stroke, March 1, 2009; 40(3): 833 - 840.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
B. Cucchiara, S. Messe, L. Sansing, S. Kasner, P. Lyden, and for the CHANT Investigators
Hematoma Growth in Oral Anticoagulant Related Intracerebral Hemorrhage
Stroke, November 1, 2008; 39(11): 2993 - 2996.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
A. Y. Zubkov, J. N. Mandrekar, D. O. Claassen, E. M. Manno, E. F. M. Wijdicks, and A. A. Rabinstein
Predictors of Outcome in Warfarin-Related Intracerebral Hemorrhage
Arch Neurol, October 1, 2008; 65(10): 1320 - 1325.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. L. Flaherty, H. Tao, M. Haverbusch, P. Sekar, D. Kleindorfer, B. Kissela, P. Khatri, B. Stettler, O. Adeoye, C. J. Moomaw, et al.
Warfarin use leads to larger intracerebral hematomas
Neurology, September 30, 2008; 71(14): 1084 - 1089.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. I. Qureshi
Acute Hypertensive Response in Patients With Stroke: Pathophysiology and Management
Circulation, July 8, 2008; 118(2): 176 - 187.
[Full Text] [PDF]

Home page
 StrokeHome page
R. E. Burgess, S. Warach, T. J. Schaewe, B. R. Copenhaver, J. R. Alger, P. Vespa, N. Martin, J. L. Saver, and C. S. Kidwell
Development and Validation of a Simple Conversion Model for Comparison of Intracerebral Hemorrhage Volumes Measured on CT and Gradient Recalled Echo MRI
Stroke, July 1, 2008; 39(7): 2017 - 2020.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
T. Steiner, J. Broderick, N. C. Brun, S. M. Davis, M. N. Diringer, S. Mayer, and B. E. Skolnick
Timing Is Everything in Intracerebral Hemorrhage
Stroke, July 1, 2008; 39(7): e117 - e118.
[Full Text] [PDF]

Home page
 NEJMHome page
S. A. Mayer, N. C. Brun, K. Begtrup, J. Broderick, S. Davis, M. N. Diringer, B. E. Skolnick, T. Steiner, and the FAST Trial Investigators
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
N. Engl. J. Med., May 15, 2008; 358(20): 2127 - 2137.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. Tuhrim
Intracerebral Hemorrhage -- Improving Outcome by Reducing Volume?
N. Engl. J. Med., May 15, 2008; 358(20): 2174 - 2176.
[Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
J. Kim, A. Smith, J.C. Hemphill III, W.S. Smith, Y. Lu, W.P. Dillon, and M. Wintermark
Contrast Extravasation on CT Predicts Mortality in Primary Intracerebral Hemorrhage
AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 520 - 525.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
M W Lorenz, M Graf, C Henke, M Hermans, U Ziemann, M Sitzer, and C Foerch
Anthropometric approximation of body weight in unresponsive stroke patients
J. Neurol. Neurosurg. Psychiatry, December 1, 2007; 78(12): 1331 - 1336.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. Claassen, N. Jette, F. Chum, R. Green, M. Schmidt, H. Choi, J. Jirsch, J. A. Frontera, E. S. Connolly, R. G. Emerson, et al.
Electrographic seizures and periodic discharges after intracerebral hemorrhage
Neurology, September 25, 2007; 69(13): 1356 - 1365.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
K. M. Thompson, S. Y. Gerlach, H. K. S. Jorn, J. M. Larson, T. G. Brott, and J. A. Files
Advances in the Care of Patients With Intracerebral Hemorrhage
Mayo Clin. Proc., August 1, 2007; 82(8): 987 - 990.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
P. D. Lyden, A. Shuaib, K. R. Lees, A. Davalos, S. M. Davis, H.-C. Diener, J. C. Grotta, T. J. Ashwood, H.-G. Hardemark, H. H. Svensson, et al.
Safety and Tolerability of NXY-059 for Acute Intracerebral Hemorrhage: The CHANT Trial
Stroke, August 1, 2007; 38(8): 2262 - 2269.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
R. Wada, R. I. Aviv, A. J. Fox, D. J. Sahlas, D. J. Gladstone, G. Tomlinson, and S. P. Symons
CT Angiography "Spot Sign" Predicts Hematoma Expansion in Acute Intracerebral Hemorrhage
Stroke, April 1, 2007; 38(4): 1257 - 1262.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. N. Goldstein, L. E. Fazen, R. Snider, K. Schwab, S. M. Greenberg, E. E. Smith, M. H. Lev, and J. Rosand
Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage
Neurology, March 20, 2007; 68(12): 889 - 894.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S. A. Mayer
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
Stroke, February 1, 2007; 38(2): 763 - 767.
[Abstract] [Full Text] [PDF]

Home page
 JWatch NeurologyHome page
Hematoma Growth as a Determinant of Mortality in ICH
Journal Watch Neurology, December 12, 2006; 2006(1212): 2 - 2.
[Full Text]

Correspondence:

Read all Correspondence

Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage
Gregory Y Chang
Neurology Online, 20 Jul 2006 [Full text]
Reply from the Authors
Stephen M Davis, et al.
Neurology Online, 13 Jul 2006 [Full text]